The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
MHC class I molecules and kirs in human history, health and survival
Abstract
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly significant differences were seen following genotyping of the mothers, suggesting a broad influence of the genetic background of NK activity, especially given that KIR/HLA complexes are expressed and active in the placenta (Guerini et al, 2014;Parham, 2005).”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Parham, 2005
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C., Gao, X., Astemborski, J. A., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M. W., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,178
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K. W., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,173
Hiby, S. E., Walker, J. J., O’Shaughnessy, K. M., Redman, C. W. G., Carrington, M. N., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,134
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B. C., Tyan, D. B., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,060
Self-citationKIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 984
Self-citationAshkar, A. A., Santo, J. P. D., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 847
Flagged first, then by citations
Cited by
Sorted by citations
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,207
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdiş, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 1,007
Targeting natural killer cells and natural killer T cells in cancer
Vivier, É., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3174 · Cited by 897
Immunology of placentation in eutherian mammals
Moffett, A., & Loke, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1897 · Cited by 855
González-Galarza, F. F., Christmas, S. E., Middleton, D., & Jones, A. R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1128 · Cited by 720
Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J. J., Gao, Z., Fox, B. A., Haldeman, B. A., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 747
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
REVIEW ARTICLE: Immunology of Pre‐Eclampsia
Redman, C. W. G., & Sargent, I. L. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00831.x · Cited by 693
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Melero, I., Berman, D. M., Aznar, M. A., Korman, A. J., Perez‐Gracia, J. L., & Haanen, J. B. A. G. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3973 · Cited by 641
Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M., Pende, D., Perruccio, K., Burchielli, E., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038687 · Cited by 604
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 602
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 607
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health
Arck, P., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 609
Cooley, S., Weisdorf, D. J., Guethlein, L. A., Klein, J. P., Wang, T., Le, C. T., Marsh, S. G. E., Geraghty, D. E., Spellman, S. R., Haagenson, M. D., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283051 · Cited by 591
Self-citationNK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wang, W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00368 · Cited by 623
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
Cossarizza, A., Chang, H., Radbruch, A., Akdiş, M., Andrä, I., Annunziato, F., Bächer, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 594
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Sivori, S., Vacca, P., Zotto, G. D., Munari, E., Mingari, M., & Moretta, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0206-4 · Cited by 493
The shaping of modern human immune systems by multiregional admixture with archaic humans
Abi-Rached, L., Jobin, M. J., Kulkarni, S., McWhinnie, A., Dalva, K., Gragert, L., Babrzadeh, F., Gharizadeh, B., Luo, M., Plummer, F. A., et al. (2011) · Science · doi:10.1126/science.1209202 · Cited by 537
Self-citationThe Role of the Immune System in Autism Spectrum Disorder
Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Immune Modulation in Cancer with Antibodies
Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P., & Wolchok, J. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-092012-112807 · Cited by 523
Yawata, M., Yawata, N., Draghi, M., Little, A., Partheniou, F., & Parham, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051884 · Cited by 515
Self-citationMaternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
Hiby, S. E., Apps, R., Sharkey, A., Farrell, L. E., Gardner, L., Mulder, A., Claas, F. H. J., Walker, J. J., Redman, C. C., Morgan, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43998 · Cited by 520
Béziat, V., Liu, L. L., Malmberg, J.-A., Ivarsson, M. A., Sohlberg, E., Björklund, A. T., Retière, C., Sverremark‐Ekström, E., Traherne, J. A., Ljungman, P. T., et al. (2013) · Blood · doi:10.1182/blood-2012-10-459545 · Cited by 503
Balancing natural killer cell activation through paired receptors
Martinet, L., & Smyth, M. J. (2015) · Nature reviews. Immunology · doi:10.1038/nri3799 · Cited by 493
Parham, P., & Moffett, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3370 · Cited by 489
Self-citationVivier, É., Rebuffet, L., Narni-Mancinelli, É., Cornen, S., Igarashi, R., & Fantin, V. R. (2024) · Nature · doi:10.1038/s41586-023-06945-1 · Cited by 496
T cell subset-specific susceptibility to aging
Czesnikiewicz-Guzik, M., Lee, W.-W., Cui, D., Hiruma, Y., Lamar, D. L., Yang, Z.-Z., Ouslander, J. G., Weyand, C. M., & Goronzy, J. J. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.12.002 · Cited by 478
The relationship between blood groups and disease
Anstee, D. J. (2010) · Blood · doi:10.1182/blood-2010-01-261859 · Cited by 480
Pesce, S., Greppi, M., Tabellini, G., Rampinelli, F., Parolini, S., Olive, D., Moretta, L., Moretta, A., & Marcenaro, E. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.025 · Cited by 476
Cooley, S., Trachtenberg, E., Bergemann, T. L., Saeteurn, K., Klein, J. P., Le, C. T., Marsh, S. G. E., Guethlein, L. A., Parham, P., Miller, J. S., et al. (2008) · Blood · doi:10.1182/blood-2008-07-171926 · Cited by 433
Self-citationThe immunogenetics of multiple sclerosis: A comprehensive review
Hollenbach, J. A., & Oksenberg, J. R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.010 · Cited by 423
Natural killer cell biology: An update and future directions
Campbell, K. S., & Hasegawa, J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.006 · Cited by 437
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vely, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 403
Şahin, İ. H., Akce, M., Alese, O. B., Shaib, W. L., Lesinski, G. B., El‐Rayes, B. F., & Wu, C. S.-Y. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0599-y · Cited by 404
Pende, D., Falco, M., Vitale, M., Cantoni, C., Vitale, C., Munari, E., Bertaina, A., Moretta, F., Zotto, G. D., Pietra, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01179 · Cited by 390
Negative signaling by inhibitory receptors: the NK cell paradigm
Long, E. O. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00660.x · Cited by 381
Apps, R., Murphy, S. P., Fernando, R., Gardner, L., Ahad, T., & Moffett, A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.03019.x · Cited by 370
The Yin and Yang of HLA and KIR in human disease
Kulkarni, S., Martin, M. P., & Carrington, M. N. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.06.003 · Cited by 362
NK Cell-Based Immune Checkpoint Inhibition
Khan, M. B., Arooj, S., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00167 · Cited by 367
Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., van der Meer, A., Joosten, I., & Long, E. O. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040009 · Cited by 362
Reconstructing immune phylogeny: new perspectives
Litman, G. W., Cannon, J. P., & Dishaw, L. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1712 · Cited by 352
The diagnosis and management of NK/T-cell lymphomas
Tse, E., & Kwong, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0452-9 · Cited by 350
Solberg, O. D., Mack, S. J., Lancaster, A. K., Single, R. M., Tsai, Y., Sanchez‐Mazas, A., & Thomson, G. J. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.001 · Cited by 345
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
Peppa, D., Gill, U. S., Reynolds, G., Easom, N. J. W., Pallett, L. J., Schurich, A., Micco, L., Nebbia, G., Singh, H. D., Adams, D. H., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121172 · Cited by 342
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F., Marubbi, D., Spaziante, R., Bellora, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802845 · Cited by 334
Hiby, S. E., Regan, L., Lo, W., Farrell, L. E., Carrington, M. N., & Moffett, A. (2008) · Human Reproduction · doi:10.1093/humrep/den011 · Cited by 337
Natural killer cells in human health and disease
Orange, J. S., & Ballas, Z. K. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.10.011 · Cited by 320
Yawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A., & Parham, P. (2008) · Blood · doi:10.1182/blood-2008-03-143727 · Cited by 323
Self-citationToward eliminating HLA class I expression to generate universal cells from allogeneic donors
Torikai, H., Reik, A., Soldner, F., Warren, E. H., Yuen, C. H.-L., Zhou, Y., Crossland, D. L., Huls, H. M., Littman, N., Zhang, Z., et al. (2013) · Blood · doi:10.1182/blood-2013-03-478255 · Cited by 312
The extensive polymorphism of KIR genes
Middleton, D., & Gonzelez, F. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03208.x · Cited by 301
Natural killer cell-mediated immunosurveillance of human cancer
Malmberg, K., Carlsten, M., Björklund, A. T., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 301
Comparative Genomics of Natural Killer Cell Receptor Gene Clusters
Kelley, J., Walter, L., & Trowsdale, J. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010027 · Cited by 290
The Role of Natural Killer Cells in Autoimmune Diseases
Küçüksezer, U. C., Çetin, E. A., Esen, F., Tahralı, İ., Akdeniz, N., Gelmez, M. Y., & Deniz, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622306 · Cited by 300
Miller, J. S., Cooley, S., Parham, P., Farag, S. S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E., Haagenson, M. D., Horowitz, M. M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065383 · Cited by 286
Self-citationBryceson, Y. T., Ljunggren, H., & Long, E. O. (2009) · Blood · doi:10.1182/blood-2009-01-201632 · Cited by 285
Surface NK receptors and their ligands on tumor cells
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., & Moretta, A. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.002 · Cited by 282
KIR and disease: a model system or system of models?
Khakoo, S. I., & Carrington, M. N. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00459.x · Cited by 281
Uniquely human evolution of sialic acid genetics and biology
Varki, A. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914634107 · Cited by 284
NK cells and ILCs in tumor immunotherapy
Sivori, S., Pende, D., Quatrini, L., Pietra, G., Chiesa, M. D., Vacca, P., Tumino, N., Moretta, F., Mingari, M. C., Locatelli, F., et al. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100870 · Cited by 279
Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcRγ Deficiency
Zhang, T., Scott, J. M., Hwang, I., & Kim, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203034 · Cited by 277
The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense
Bashirova, A. A., Martin, M. P., McVicar, D. W., & Carrington, M. N. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115726 · Cited by 266
HLA alleles determine differences in human natural killer cell responsiveness and potency
Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y.-J., French, A. R., Vlahiotis, A., Piccirillo, J. F., Cella, M., Colonna, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712229105 · Cited by 261
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Mehta, R. S., & Rezvani, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00283 · Cited by 264
Vacca, P., Cantoni, C., Vitale, M., Prato, C., Canegallo, F., Fenoglio, D., Ragni, N., Moretta, L., & Mingari, M. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001749107 · Cited by 266
Kawase, T., Morishima, Y., Matsuo, K., Kashiwase, K., Inoko, H., Saji, H., Kato, S., Juji, T., Kodera, Y., & Sasazuki, T. (2007) · Blood · doi:10.1182/blood-2007-02-072405 · Cited by 253
Chiesa, M. D., Falco, M., Podestà, M., Locatelli, F., Moretta, L., Frassoni, F., & Moretta, A. (2011) · Blood · doi:10.1182/blood-2011-08-372003 · Cited by 251
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Willemze, R., Arrais‐Rodrigues, C., Labopin, M., Sanz, G. F., Michel, G., Socié, G., Rio, B., Sîrvent, A., Renaud, M., Madero, L., et al. (2009) · Leukemia · doi:10.1038/leu.2008.365 · Cited by 244
Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C. E., André, P., Efebera, Y. A., Tiollier, J., et al. (2012) · Blood · doi:10.1182/blood-2012-06-438028 · Cited by 251
Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice
Gaynor, L. M., & Colucci, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00467 · Cited by 250
The genetics of pre-eclampsia and other hypertensive disorders of pregnancy
Williams, P. J., & Broughton Pipkin, F. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.02.007 · Cited by 240
Graef, T. T., Moesta, A. K., Norman, P. J., Abi‐Rached, L., Vago, L., Aguilar, A. M. O., Gleimer, M., Hammond, J. A., Guethlein, L. A., Bushnell, D. A., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091010 · Cited by 245
Self-citationPyo, C., Guethlein, L. A., Vu, Q., Wang, R., Abi‐Rached, L., Norman, P. J., Marsh, S. G. E., Miller, J. S., Parham, P., & Geraghty, D. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015115 · Cited by 238
Self-citationCarter, A. M. (2012) · Physiological Reviews · doi:10.1152/physrev.00040.2011 · Cited by 244
Current perspectives of natural killer cell education by MHC class I molecules
Höglund, P., & Brodin, P. (2010) · Nature reviews. Immunology · doi:10.1038/nri2835 · Cited by 256
Human MHC architecture and evolution: implications for disease association studies
Traherne, J. A. (2008) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2008.00765.x · Cited by 239
Immunoporosis: Role of Innate Immune Cells in Osteoporosis
Saxena, Y., Routh, S., & Mukhopadhaya, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687037 · Cited by 233
Global diversity and evidence for coevolution of KIR and HLA
Single, R. M., Martin, M. P., Gao, X., Meyer, D., Yeager, M., Kidd, J. R., Kídd, K. K., & Carrington, M. N. (2007) · Nature Genetics · doi:10.1038/ng2077 · Cited by 229
Human natural killer cell deficiencies
Orange, J. S. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3280106b65 · Cited by 229
Immunogenetics of type 1 diabetes: a comprehensive review
Noble, J. A. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.014 · Cited by 227
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
Tarek, N., Luduec, J.-B. L., Gallagher, M. M., Zheng, J., Venstrom, J. M., Chamberlain, E., Modak, S. I., Heller, G., Dupont, B., Cheung, N. V., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62749 · Cited by 229
Class I HLA haplotypes form two schools that educate NK cells in different ways
Horowitz, A., Djaoud, Z., Nemat‐Gorgani, N., Blokhuis, J. H., Hilton, H. G., Béziat, V., Malmberg, K., Norman, P. J., Guethlein, L. A., & Parham, P. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag1672 · Cited by 222
Self-citationUnderstanding how combinations of HLA and KIR genes influence disease
Rajagopalan, S., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050499 · Cited by 218
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function
Montaldo, E., Zotto, G. D., Chiesa, M. D., Mingari, M. C., Moretta, A., Maria, A. D., & Moretta, L. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22302 · Cited by 216
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans
Norman, P. J., Abi‐Rached, L., Gendzekhadze, K., Korbel, D. S., Gleimer, M., Rowley, D., Bruno, D., Carrington, C. V. F., Chandanayingyong, D., Chang, Y.-H., et al. (2007) · Nature Genetics · doi:10.1038/ng2111 · Cited by 218
Self-citationBenson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., Hofmeister, C. C., Efebera, Y. A., André, P., Romagné, F., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360255 · Cited by 207
Cell-Cell Communication in the Tumor Microenvironment, Carcinogenesis, and Anticancer Treatment
Brücher, B. L. D. M., & Jamall, I. S. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362978 · Cited by 210
KIR2DL4 (CD158d): An activation receptor for HLA-G
Rajagopalan, S., & Long, E. O. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00258 · Cited by 214
Chan, A. T. Y., Kollnberger, S., Wedderburn, L. R., & Bowness, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21395 · Cited by 200
Parham, P., Norman, P. J., Abi‐Rached, L., & Guethlein, L. A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0266 · Cited by 200
Self-citationDraghi, M., Pashine, A., Sanjanwala, B. M., Gendzekhadze, K., Cantoni, C., Cosman, D. J., Moretta, A., Valiante, N. M., & Parham, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2688 · Cited by 203
Self-citationKiller cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B
Vivian, J. P., Duncan, R. C., Berry, R., O’Connor, G. M., Reid, H. H., Beddoe, T., Gras, S., Saunders, P. M., Olshina, M. A., Widjaja, J. M. L., et al. (2011) · Nature · doi:10.1038/nature10517 · Cited by 194
Human NK cells, their receptors and function
Quatrini, L., Chiesa, M. D., Sivori, S., Mingari, M. C., Pende, D., & Moretta, L. (2021) · European Journal of Immunology · doi:10.1002/eji.202049028 · Cited by 202
de Rham, C., Ferrari‐Lacraz, S., Jendly, S., Schneiter, G., Dayer, J., & Villard, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2336 · Cited by 186
Jennes, W., Verheyden, S. J., Demanet, C. J., Adjé-Touré, C., Vuylsteke, B., Nkengasong, J. N., & Kestens, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6588 · Cited by 180
Metadata
- Authors
- Parham, P.
- Affiliations
- Stanford University (US)
- Corresponding author
- Parham, Peter
- ORCID
- Parham, Peter
- Venue
- Nature Reviews Immunology
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 201-214
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2008919922
- Cited by
- 1,203
- References
- 125
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 35 · 2023: 23 · 2022: 44 · 2021: 38 · 2020: 43 · 2019: 54 · 2018: 46 · 2017: 50 · 2016: 57 · 2015: 55 · 2014: 57 · 2013: 95 · 2012: 77
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- MHC class I, killer cell immunoglobulin-like receptors, natural killer cells, T cells, infection resistance, autoimmune disease susceptibility, pregnancy complications, hematopoietic stem cell transplantation, human survival, immune system evolution, reproduction
- MeSH terms
- Animals, Autoimmune Diseases, Communicable Diseases, Humans, Lymphocytes, Neoplasms, Receptors, Immunologic, Histocompatibility Antigens Class I, Models, Immunological, Evolution, Molecular, Receptors, KIR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review